- Oxford Covid-19 vaccine is "generating the kind of antibody and T-cell (killer cell) response that the researchers would hope to see" - ITV political editor
Market news
15 July 2020
Oxford Covid-19 vaccine is "generating the kind of antibody and T-cell (killer cell) response that the researchers would hope to see" - ITV political editor
"I am hearing there will be positive news soon (perhaps tomorrow) on initial trials of the Oxford Covid-19 vaccine that is backed by AstraZeneca and supported by tens of millions of pounds of government money," reports ITV political editor Robert Peston. "Apparently the vaccine is generating the kind of antibody and T-cell (killer cell) response that the researchers would hope to see." The first data are reported to be published in the Lancet.
Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerOpen Demo Account & Personal Page